| Literature DB >> 31698834 |
Ghita Amor1,2, Lucia Caputo3, Antonietta La Storia2, Vincenzo De Feo3, Gianluigi Mauriello2, Taoufiq Fechtali1.
Abstract
Essential oils (EOs) are one of the most important groups of plant metabolites responsible for their biological activities. This study was carried out to study the chemical composition and the antimicrobial effects of Artemisia herba-alba and Origanum majorana essential oils against some Gram-positive and Gram-negative bacteria, and a fungal strain isolated from spoiled butter. The plants were collected in the region Azzemour of South West Morocco and the EOs, extracted by hydrodistillation, were analyzed by GC-MS. The antimicrobial activity was determined using the agar paper disc method. The main components of A. herba-alba EO were cis-thujone, trans-thujone and vanillyl alcohol; in O. majorana EO terpinen-4-ol, isopulegol and β-phellandrene predominated. Both essential oils exhibited growth inhibiting activities in a concentration-dependent manner on several microorganism species. Our results demonstrated that O. majorana and A. herba-alba EOs could be effective natural antibacterial agents in foods.Entities:
Keywords: Artemisia herba-alba; Origanum majorana; antimicrobial activity; chemical characterization; essential oils
Mesh:
Substances:
Year: 2019 PMID: 31698834 PMCID: PMC6891654 DOI: 10.3390/molecules24224021
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Chemical composition of Artemisia herba-alba essential oil.
| Compound | % | Ki a | Ki b | Identification c |
|---|---|---|---|---|
| 4.5 | 1048 | 1,2 | ||
| 25.5 | 1079 | 1102 | 1,2,3 | |
| 17.7 | 1111 | 1114 | 1,2,3 | |
| Camphor | 4.9 | 1150 | 1146 | 1,2,3 |
| 7.8 | 1200 | 1231 | 1,2 | |
| 4.7 | 1231 | 1265 | 1,2 | |
| Undec-10-en-1-al | 1.3 | 1261 | 1296 | 1,2 |
| Cyclosativene | T | 1342 | 1368 | 1,2 |
| 5.8 | 1386 | 1415 | 1,2 | |
| Vanillyl Alcohol | 11.5 | 1424 | 1447 | 1,2 |
| 3.1 | 1445 | 1470 | 1,2 | |
| Isobornyl | 4.9 | 1466 | 1491 | 1,2 |
| <E>-Jasmolactone | 3.4 | 1483 | 1491 | 1,2 |
| Artedouglasia Oxide C | 2.5 | 1496 | 1523 | 1,2 |
| Total | 97.6 | |||
| Oxygenated monoterpene | 56.4 | |||
| Oxygenated sesquiterpenes | 2.5 | |||
| Other compounds | 38.7 |
a Kovats retention index on HP-5 MS column; b Kovats retention index on HP Innovax column; c Identification: 1 = Kovats retention index, 2 = mass spectrum, 3 = co-injection with pure compound; T = traces, less than 0.05%.
Chemical composition of Origanum majorana essential oil.
| Compound | % | KI a | KI b | Identification c |
|---|---|---|---|---|
| α-Pinene | 4.1 | 941 | 932 | 1,2,3 |
| p-Cymene | 2.6 | 950 | 1024 | 1,2,3 |
| 0.6 | 952 | 1008 | 1,2,3 | |
| β-Pinene | 0.2 | 975 | 974 | 1,2,3 |
| α-Phellandrene | 2.6 | 984 | 1002 | 1,2,3 |
| δ-3-Carene | 1.9 | 1008 | 1011 | 1,2 |
| α-Terpinene | 19.2 | 1021 | 1017 | 1,2,3 |
| Limonene | 0.1 | 1038 | 1029 | 1,2,3 |
| 1,8 Cineole | 3.0 | 1047 | 1031 | 1,2,3 |
| β-Ocimene | 0.1 | 1061 | 1037 | 1,2,3 |
| 1.3 | 1070 | 1070 | 1,2 | |
| Terpinen-4-ol | 34.1 | 1096 | 1149 | 1,2,3 |
| 9.8 | 1114 | 1220 | 1,2 | |
| Pulegone | 0.7 | 1122 | 1237 | 1,2 |
| 0.3 | 1143 | 1139 | 1,2 | |
| Terpineol | 8.9 | 1160 | 1133 | 1,2,3 |
| T | 1188 | 1136 | 1,2 | |
| dihydro-Linalool | 0.1 | 1191 | 1135 | 1,2 |
| T | 1193 | 1141 | 1,2,3 | |
| Viridene | 0.1 | 1199 | 1167 | 1,2 |
| (E)-Isocitral | 0.2 | 1205 | 1180 | 1,2 |
| Thymol | 0.2 | 1211 | 1290 | 1,2,3 |
| Carvacrol | 0.3 | 1220 | 1299 | 1,2,3 |
| γ-Elemene | 0.1 | 1233 | 1338 | 1,2,3 |
| α-Terpinyl acetate | 0.8 | 1242 | 1349 | 1,2 |
| Eugenol | T | 1271 | 1359 | 1,2,3 |
| Neryl acetate | 0.2 | 1274 | 1361 | 1,2 |
| α-Copaene | T | 1278 | 1376 | 1,2,3 |
| Geranyl acetate | 0.3 | 1293 | 1381 | 1,2,3 |
| 0.1 | 1303 | 1390 | 1,2 | |
| (E)-Caryophillene | 2.1 | 1314 | 1407 | 1,2,3 |
| β-Duprezianene | T | 1321 | 1422 | 1,2 |
| β-Cedrene | T | 1324 | 1420 | 1,2,3 |
| β-Copaene | T | 1327 | 1432 | 1,2,3 |
| α-Guaiene | 0.2 | 1332 | 1439 | 1,2,3 |
| Aromadendrene | 0.3 | 1336 | 1441 | 1,2,3 |
| 1.3 | 1370 | 1460 | 1,2 | |
| Valencene | 0.2 | 1401 | 1496 | 1,2,3 |
| Caryophyllene oxide | T | 1436 | 1583 | 1,2,3 |
| Epiglobulol | T | 1445 | 1590 | 1,2 |
| (-)-Spathulenol | T | 1453 | 1578 | 1,2 |
| β-Atlanthol | 1.6 | 1464 | 1608 | 1,2,3 |
| Rosifoliol | 0.1 | 1485 | 1600 | 1,2 |
| Cubenol | T | 1497 | 1646 | 1,2 |
| Total | 97.8 | |||
| Monoterpene hydrocarbons | 33.1 | |||
| Oxygenated monoterpene | 57.9 | |||
| Sesquiterpene hydrocarbons | 5.1 | |||
| Oxygenated sesquiterpenes | 1.7 |
a Kovats retention index on HP-5 MS column; b Kovats retention index on HP Innovax column; c Identification: 1 = Kovats retention index, 2 = mass spectrum, 3 = co-injection with pure compound. T = traces, less than 0.05%.
Figure 1Representative antimicrobial activity of (A) Origanum majorana essential oil against Brochothrix thermosphacta D274 at the dose of 50, 40, 20, and 15 µL (from 1 to 4, respectively) and (B) Artemisia herba-alba essential oil against Bacillus clausii 2226 at the concentrations of 20, 15, 10, and 5 µL (from 1 to 4, respectively).
Antibacterial activity of the essential oil of A. herba-alba.
| Strain | Control | Essential Oil | ||||
|---|---|---|---|---|---|---|
| Gentamicin | Tetracyclin | 5 μL | 10 μL | 15 μL | 20 μL | |
|
| 11.0 ± 1.0 | 16.3 ± 1.5 | 10.3 ± 0.6 | 14.7 ± 0.6 | 19.7 ± 1.5 a,D | 24.0 ± 1.0 a,A |
| 18.3 ± 1.5 | 19.3 ± 1.2 | na | 6.0 ± 0.0 | 6.0 ± 0.1 | 12.3 ± 0.6 | |
| 6.0 ± 0.0 | 8.7 ± 1.2 | 6.0 ± 0.0 | 11.7 ± 0.6 a,C | 14.7 ± 0.6 a,A | 17.7 ± 0.6 a,A | |
| 6.0 ± 0.0 | 24.3 ± 1.2 | 6.0 ± 0.0 | 9.0 ± 1.0 b | 11.7 ± 0.6 a | 12.3 ± 0.6 a | |
| 6.0 ± 0.0 | 22.3 ± 0.6 | na | na | na | na | |
| 6.0 ± 0.0 | 23.3 ± 1.5 | na | na | na | na | |
| 10.0 ± 0.0 | na | na | na | na | 6.0 ± 0.0 A | |
| 14.7 ± 0.6 | 18.7 ± 1.2 | na | na | 6.0 ± 0.0 | 6.0 ± 0.0 | |
| 6.0 ± 0.0 | 9.0 ± 1.0 | na | na | na | na | |
| 6.0 ± 0.0 | 14.7 ± 0.6 | na | na | na | na | |
| 11.7 ± 1.5 | 9.7 ± 0.6 | na | na | na | na | |
| 25.3 ± 0.6 | 20.3 ± 1.5 | na | na | na | 6.0 ± 0.0 | |
| 14.7 ± 0.6 | 17.0 ± 1.0 | na | 6.0 ± 0.0 | 9.3 ± 0.6 | 13.3 ± 2.1 | |
|
| 6.0 ± 0.0 | 15.3 ± 0.6 | na | na | na | 6.0 ± 0.0 |
| 9.7 ± 0.6 | 12.7 ± 1.2 | na | 6.0 ± 0.0 | 14.0 ± 1.7 b | 17.7 ± 0.6 a,B | |
| 12.3 ± 0.6 | 24.3 ± 1.2 | na | 6.0 ± 0.0 | 7.7 ± 0.6 | 10.3 ± 0.6 | |
|
| 6.0 ± 0.0 | 18.7 ± 1.2 | na | 6.0 ± 0.0 | 14.0 ± 1.0 a | 18.3 ± 1.5 a |
| 24.0 ± 1.0 | 29.0 ± 3.6 | na | na | 6.0 ± 0.0 | 6.0 ± 0.0 | |
| 19.3 ± 1.2 | 29.3 ± 1.2 | na | 6.0 ± 0.0 | 8.3 ± 0.6 | 10.3 ± 0.6 | |
| 21.3 ± 1.2 | 27.7 ± 2.5 | 6 ± 0.0 | 11.3 ± 1.2 | 14.7 ± 0.6 | 17 ± 1.0 | |
Data represent the diameter inhibition (in mm). Results are the mean of three repetitions ± standard deviation (SD) of the inhibition zone. na = not active. Dunnett’s test vs. Gentamicin (a,b,c,d) or Tetracycline (A,B,C,D): a,A p < 0.0001; b,B p < 0.001; c,C p < 0.01; d,D p < 0.05. B.: Bacillus; Br.: Brochothrix; C.: Carnobacterium; E.: Enterococcus; Staph.: Staphylococcus; L.: Listeria; E.: Escherichia; H.: Hafnia; P.: Pseudomonas; S.: Salmonella; Serr.: Serratia; Str.: Streptococcus.
Activity of the essential oil of O. majorana.
| Strain | Control | Essential Oil | ||||||
|---|---|---|---|---|---|---|---|---|
| Gentamicin | Tetracyclin | 5 µL | 10 µL | 15 µL | 20 µL | 40 µL | 50 µL | |
| 11.0 ± 1.0 | 16.3 ± 1.5 | na | 6.0 ± 0.0 | 15.3 ± 0.6b | 23.3 ± 1.5 a,B | 24.7 ± 0.6 a,B | 28.3 ± 1.5 a,B | |
| 6.0 ± 0.0 | 8.7 ± 1.2 | 10.6 ± 0.6d | 13.3 ± 1.2 a | 18.3 ± 0.6 a,B | 23.0 ± 1.7 a,B | 24.3 ± 1.2 a,B | 26.3 ± 1.2 a,B | |
| 18.3 ± 1.5 | 19.3 ± 1.2 | 11.3 ± 1.2 | 15.3 ± 0.6 | 18.0 ± 0.0 | 20.3 ± 0.6* | 20.0 ± 0.0 | 21.3 ± 0.6c,D | |
| 6.0 ± 0.0 | 24.3 ± 1.2 | na | na | na | 6.0 ± 0.0 | 6.0 ± 0.0 | 9.3 ± 0.6a | |
| 10.0 ± 0.0 | na | 6.0 ± 0.0A | 6.0 ± 0.0 A | 8.7 ± 1.2 A | 9.7 ± 0.6 A | 9.3 ± 0.6 A | 9.7 ± 0.6 A | |
| 6.0 ± 0.0 | 22.3 ± 0.6 | na | na | na | 6.0 ± 0.0 | 9.3 ± 0.6 a | 13.3 ± 1.5 a | |
| 6.0 ± 0.0 | 23.3 ± 1.5 | na | na | na | 6.0 ± 0.0 | 6.0 ± 0.0 | 6.0 ± 0.0 | |
| 14.7 ± 0.6 | 18.7 ± 1.2 | 9.7 ± 0.6 | 10.7 ± 1.2 | 17.7 ± 0.6 | 20.0 ± 0.0 a | 24.3 ± 1.2 a,B | 26.7 ± 0.6 a,B | |
| 6.0 ± 0.0 | 9.0 ± 1.0 | na | na | na | 6.0 ± 0.0 | 6.0 ± 0.1 | 9.7 ± 0.7 | |
| 6.0 ± 0.0 | 14.7 ± 0.6 | na | na | na | 6.0 ± 0.0 | 6.0 ± 0.0 | 6.0 ± 0.0 | |
| 11.7 ± 1.5 | 9.7 ± 0.6 | 8.3 ± 0.6 | 10.3 ± 0.6 | 11.7 ± 0.6 C | 12.7 ± 0.6 A | 15.0 ± 0.0 b,A | 20.3 ± 0.6 a,B | |
| 25.3 ± 0.6 | 20.3 ± 1.5 | na | 6.0 ± 0.0 | 9.3 ± 0.6 | 11.7 ± 0.6 | 12.3 ± 0.6 | 13.7 ± 1.5 | |
| 14.7 ± 0.6 | 17.0 ± 1.0 | na | na | 6.0 ± 0.0 | 6.0 ± 0.0 | 6.0 ± 0.0 | 9.3 ± 0.6 | |
|
| 6.0 ± 0.0 | 15.3 ± 0.6 | 10.7 ± 0.6 d | 11.7 ± 1.5 c | 16.3 ± 1.5 a | 24.3 ± 2.1 a,B | 27.7 ± 0.6 a,B | 32.3 ± 2.5 a,B |
| 9.7 ± 0.6 | 12.7 ± 1.2 | 7.7 ± 2.1 | 11.7 ± 0.6 | 14.0 ± 1.7 d | 17.3 ± 1.2 c,D | 23.3 ± 2.9 a,B | 29.7 ± 0.6 a,B | |
| 12.3 ± 0.6 | 24.3 ± 1.2 | na | na | na | 6.0 ± 0.0 | 16.3 ± 1.5a | 19.3 ± 1.2a | |
|
| 6.0 ± 0.0 | 18.7 ± 1.2 | 9.7 ± 0.6 c | 11.3 ± 0.6 a | 13.0 ± 1.0 a | 19.3 ± 1.2 a | 20.7 ± 1.2 a | 24.3 ± 1.2 a,B |
| 24.0 ± 1.0 | 29.0 ± 3.6 | 9.9 ± 1.0 | 11.7 ± 0.6 | 19.3 ± 1.2 | 20.3 ± 0.6 | 21.0 ± 1.0 | 24.3 ± 1.2 | |
| 19.3 ± 1.2 | 29.3 ± 1.2 | 6.0 ± 0.0 | 6.0 ± 0.0 | 14.7 ± 7.6 | 18.7 ± 1.2 | 20.0 ± 0.0 | 21.0 ± 1.0 | |
| 21.3 ± 1.2 | 27.7 ± 2.5 | na | na | 5.7 ± 0.6 | 10 ± 0.0 | 14.7 ± 0.6 | 19.3 ± 1.2 | |
Data represent the diameter inhibition(in mm). Results are the mean of three repetitions ± standard deviation (SD) of the inhibition zone. na = not active. Dunnett’s test vs. Gentamicin (a,b,c,d) or Tetracycline (A,B,C,D): a,A p < 0.0001; b,B p < 0.001; c,C p < 0.01; d,D p < 0.05. B.: Bacillus; Br.: Brochothrix; C.: Carnobacterium; E.: Enterococcus; Staph.: Staphylococcus; L.: Listeria; E.: Escherichia; H.: Hafnia; P.: Pseudomonas; S.: Salmonella; Serr.: Serratia; Str.: Streptococcus.
Antifungal activity of A. herba-alba and O. majorana essential oils.
|
| |
|---|---|
|
| 23.6 ± 1.5 |
|
| 14.0 ± 1.0 |
Data represent the diameter inhibition (in mm). Results are the mean of three repetitions ± standard deviation (SD) of the inhibition zone.
Figure 2Antifungal activity of A. herba-alba (1) and O. majorana (2) essential oils against Aspergillus niger at the dose of 20 µL.
Source and optimal growth conditions of microorganisms.
| Gram | Microorganism | Source | Growth Conditions |
|---|---|---|---|
|
| Supplement | TSB 24h at 30 °C | |
| Meat | TSB 24h at 20 °C | ||
| Meat | TSB 24h at 20 °C | ||
| Meat | TSB 24h at 20 °C | ||
| Meat | TSB 24h at 25 °C | ||
| Meat | TSB 24h at 25 °C | ||
| Meat | TSB 24h at 25 °C | ||
| Milk | TSB 24h at 30 °C | ||
| Milk | TSB 24h at 30 °C | ||
|
| Meat | TSB 24h at 37 °C | |
| Fermented meat | TSB 24h at 37 °C | ||
| Fermented meat | TSB 24h at 37 °C | ||
| Fermented meat | TSB 24h at 37 °C | ||
| Milk | TSB 24h at 30 °C | ||
| Meat | TSB 24h at 37 °C | ||
|
| Milk | TSB 24h at 30 °C | |
|
| Meat | TSB 24h at 30 °C | |
| Meat | TSB 24h at 20 °C | ||
| Chicken meat | TSB 24h at 30 °C | ||
| Meat | TSB 24h at 25 °C |
B.: Bacillus; Br.: Brochothrix; C.: Carnobacterium; E.: Enterococcus; Staph.: Staphylococcus; L.: Listeria; E.: Escherichia; H.: Hafnia; P.: Pseudomonas; S.: Salmonella; Serr.: Serratia; Str.: Streptococcus.